Geron (GERN) Change in Receivables (2024 - 2026)
Geron's (GERN) quarterly Change in Receivables came in at $4.9 million in Q1 2026, up 205.27% year-on-year from $1.6 million in Q1 2025, and up 209.75% quarter-over-quarter from $1.6 million in Q4 2025.
Geron (GERN) Change in Receivables (2024 - 2026) Analysis & Trends
Geron has disclosed Change in Receivables across 3 years of filings, most recently posting $4.9 million for Q1 2026.
- Change in Receivables for Q1 2026 came in at $4.9 million, up 205.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.5 million (down 66.07% YoY), and the FY2025 annual result was $991000.0, down 97.22% from the prior year.
- Change in Receivables came in at $4.9 million for Q1 2026 at Geron, up from $1.6 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $27.1 million in Q3 2024 to a low of -$4.6 million in Q1 2025.
- The 3-year median for Change in Receivables is $3.2 million (2025), against an average of $5.2 million.
- Peak annual rise in Change in Receivables reached 510.18% in 2025, while the deepest fall reached 104.69% in 2025.
- Geron's Change in Receivables stood at $7.7 million in 2024, then plunged by 79.45% to $1.6 million in 2025, then jumped by 209.75% to $4.9 million in 2026.
- The last three Change in Receivables figures came in at $4.9 million (Q1 2026), $1.6 million (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -4.08 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 4.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.89 Mn |
| Mar 31, 2026 | 4.89 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | 5.33 Mn |
| Jun 30, 2025 | 5.33 Mn |
| Mar 31, 2025 | -4.65 Mn |
| Mar 31, 2025 | -4.65 Mn |
| Dec 31, 2024 | 7.69 Mn |
| Dec 31, 2024 | 7.69 Mn |
| Sep 30, 2024 | 27.13 Mn |
| Sep 30, 2024 | 27.13 Mn |
| Jun 30, 2024 | 874,000.00 |
| Jun 30, 2024 | 874,000.00 |